Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-19 Purchase |
2024-12-23 06:03 am |
enVVeno Medical Corp | NVNO | Jenusaitis Matthew Director |
9,620 | $2.53 | $24,339 | 16,545 (Direct) |
View |
| 2021-08-25 Purchase |
2021-08-27 3:19 pm |
Hancock Jaffe Laboratories Inc. | HJLI | Jenusaitis Matthew Director |
1,300 | $7.7 | $10,010 | 4,842 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-18 Option Award |
2024-12-20 8:33 pm |
N/A 2034-12-18 |
enVVeno Medical Corp | NVNO | Jenusaitis Matthew Director |
19,752 | $0 | 19,752 (Direct) |
View |
| 2023-12-05 Option Award |
2023-12-07 5:06 pm |
N/A 2033-12-05 |
enVVeno Medical Corp | NVNO | Jenusaitis Matthew Director |
13,856 | $0 | 13,856 (Direct) |
View |
| 2022-11-30 Option Award |
2022-12-02 4:30 pm |
N/A 2032-11-30 |
enVVeno Medical Corp | NVNO | Jenusaitis Matthew Director |
8,403 | $0 | 8,403 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-16 4:05 pm |
N/A N/A |
enVVeno Medical Corp | NVNO | Jenusaitis Matthew Director |
1,041 | $0 | 6,925 (Direct) |
View |
| 2021-11-30 Option Award |
2021-12-02 4:05 pm |
N/A 2031-11-30 |
enVVeno Medical Corp | NVNO | Jenusaitis Matthew Director |
7,211 | $0 | 7,211 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-15 9:50 pm |
N/A N/A |
Hancock Jaffe Laboratories Inc. | HIJI | Jenusaitis Matthew Director |
1,042 | $0 | 7,968 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 9:58 pm |
N/A 2031-02-18 |
Hancock Jaffe Laboratories Inc. | HJLI | Jenusaitis Matthew Director |
5,673 | $0 | 5,673 (Direct) |
View |